Published in Oncotarget on March 15, 2016
The hallmarks of cancer. Cell (2000) 113.05
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell (1997) 7.27
Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem (1998) 6.84
The extracellular matrix as a cell survival factor. Mol Biol Cell (1993) 6.32
Integrins and anoikis. Curr Opin Cell Biol (1997) 5.38
TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev (2008) 4.85
Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol (2004) 4.70
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature (2002) 4.56
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature (2004) 4.53
Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell (2005) 4.14
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem (2000) 4.11
p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev (1996) 3.98
Chemosensitivity linked to p73 function. Cancer Cell (2003) 3.63
Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol (1998) 3.52
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis (2002) 2.70
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell (2003) 2.65
DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med (2002) 2.48
TP53 family members and human cancers. Hum Mutat (2003) 1.70
DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol (2004) 1.56
Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73. Cancer Res (2002) 1.47
p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB. J Cell Biol (1999) 1.46
The C terminus of p53 family proteins is a cell fate determinant. Mol Cell Biol (2005) 1.45
p53 is cleaved by caspases generating fragments localizing to mitochondria. J Biol Chem (2006) 1.30
Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem (2002) 1.29
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Breast Cancer Res Treat (2006) 1.26
Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harb Symp Quant Biol (1994) 1.24
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer (2005) 1.23
P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism. Oncogene (2011) 1.22
Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax. Cancer Lett (2003) 1.18
Overexpressed TP73 induces apoptosis in medulloblastoma. BMC Cancer (2007) 1.05
P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis. Oncogene (2008) 1.00
Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol (2014) 1.00
PRIMA-1Met/APR-246 displays high antitumor activity in multiple myeloma by induction of p73 and Noxa. Mol Cancer Ther (2013) 0.98
Nuclear import and export signals in control of the p53-related protein p73. J Biol Chem (2002) 0.95
The cleavage of Akt/protein kinase B by death receptor signaling is an important event in detachment-induced apoptosis. J Biol Chem (2001) 0.94
Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73. Cancer Biol Ther (2008) 0.93
TAp73beta and DNp73beta activate the expression of the pro-survival caspase-2S. Nucleic Acids Res (2008) 0.93
Control of p53 nuclear accumulation in stressed cells. FEBS Lett (2005) 0.92
TAp73 promotes anti-senescence-anabolism not proliferation. Aging (Albany NY) (2014) 0.91
Effects of inducible overexpression of DNp73alpha on cancer cell growth and response to treatment in vitro and in vivo. Cell Death Differ (2005) 0.86
In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs. Int J Cancer (2007) 0.84
TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity. Oncotarget (2014) 0.83
Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatment. Biochem Pharmacol (2002) 0.81
Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus. Oncotarget (2014) 0.80